Cargando…
LUM Expression and Its Prognostic Significance in Gastric Cancer
Background: Lumican (LUM) is a member of the small leucine-rich proteoglycan family and plays dual roles as an oncogene and a tumor suppressor gene. The effect of LUM on tumors is still controversial. Methods: Gene expression profiles and clinical data of gastric cancer (GC) were downloaded from The...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242722/ https://www.ncbi.nlm.nih.gov/pubmed/32500021 http://dx.doi.org/10.3389/fonc.2020.00605 |
_version_ | 1783537283055484928 |
---|---|
author | Chen, Xiaowei Li, Xin Hu, Xueju Jiang, Fei Shen, Yan Xu, Rui Wu, Leilei Wei, Pingmin Shen, Xiaobing |
author_facet | Chen, Xiaowei Li, Xin Hu, Xueju Jiang, Fei Shen, Yan Xu, Rui Wu, Leilei Wei, Pingmin Shen, Xiaobing |
author_sort | Chen, Xiaowei |
collection | PubMed |
description | Background: Lumican (LUM) is a member of the small leucine-rich proteoglycan family and plays dual roles as an oncogene and a tumor suppressor gene. The effect of LUM on tumors is still controversial. Methods: Gene expression profiles and clinical data of gastric cancer (GC) were downloaded from The Cancer Genome Atlas (TCGA) database. The expression difference of LUM in GC tissues and adjacent nontumor tissues was analyzed by R software and verified by quantitative real-time polymerase chain reaction (qRT-PCR) and comprehensive meta-analysis. The relationship between LUM expression and clinicopathological parameters was assessed by chi-square test and logistic regression. Kaplan–Meier survival analysis and Cox proportional hazards regression model were chosen to assess the effect of LUM expression on survival. Gene set enrichment analysis (GSEA) was used to screen the signaling pathways involved in GC between the low and the high LUM expression datasets. Results: The expression of LUM in GC tissues was significantly higher than that in adjacent nontumor tissues (P < 0.001) from the TCGA database. qRT-PCR (P = 0.022) and comprehensive meta-analysis (standard mean difference = 0.90, 95% CI: 0.34–1.46) demonstrated that LUM was upregulated in GC. The chi-square test showed that the high expression of LUM was correlated with tumor differentiation (P = 0.024) and T stage (P = 0.004). Logistic regression analysis showed that high LUM expression was significantly correlated with tumor differentiation (OR = 1.543 for poor vs. well or moderate, P = 0.043), pathological stage (OR = 3.149 for stage II vs. stage I, P = 0.001; OR = 2.505 for stage III vs. stage I, P = 0.007), and T classification (OR = 13.304 for T2 vs. T1, P = 0.014; OR = 18.434 for T3 vs. T1, P = 0.005; OR = 30.649 for T4 vs. T1, P = 0.001). The Kaplan–Meier curves suggested that patients with high LUM expression had a poor prognosis. Multivariate analysis showed that a high expression of LUM was an important independent predictor of poor overall survival (HR, 1.189; 95% CI, 1.011–1.400; P = 0.037). GSEA indicated that 14 signaling pathways were evidently enriched in samples with the high-LUM expression phenotype. Conclusions: LUM might act as an oncogene in the progression of GC and could be regarded as a potential prognostic indicator and therapeutic target for GC. |
format | Online Article Text |
id | pubmed-7242722 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72427222020-06-03 LUM Expression and Its Prognostic Significance in Gastric Cancer Chen, Xiaowei Li, Xin Hu, Xueju Jiang, Fei Shen, Yan Xu, Rui Wu, Leilei Wei, Pingmin Shen, Xiaobing Front Oncol Oncology Background: Lumican (LUM) is a member of the small leucine-rich proteoglycan family and plays dual roles as an oncogene and a tumor suppressor gene. The effect of LUM on tumors is still controversial. Methods: Gene expression profiles and clinical data of gastric cancer (GC) were downloaded from The Cancer Genome Atlas (TCGA) database. The expression difference of LUM in GC tissues and adjacent nontumor tissues was analyzed by R software and verified by quantitative real-time polymerase chain reaction (qRT-PCR) and comprehensive meta-analysis. The relationship between LUM expression and clinicopathological parameters was assessed by chi-square test and logistic regression. Kaplan–Meier survival analysis and Cox proportional hazards regression model were chosen to assess the effect of LUM expression on survival. Gene set enrichment analysis (GSEA) was used to screen the signaling pathways involved in GC between the low and the high LUM expression datasets. Results: The expression of LUM in GC tissues was significantly higher than that in adjacent nontumor tissues (P < 0.001) from the TCGA database. qRT-PCR (P = 0.022) and comprehensive meta-analysis (standard mean difference = 0.90, 95% CI: 0.34–1.46) demonstrated that LUM was upregulated in GC. The chi-square test showed that the high expression of LUM was correlated with tumor differentiation (P = 0.024) and T stage (P = 0.004). Logistic regression analysis showed that high LUM expression was significantly correlated with tumor differentiation (OR = 1.543 for poor vs. well or moderate, P = 0.043), pathological stage (OR = 3.149 for stage II vs. stage I, P = 0.001; OR = 2.505 for stage III vs. stage I, P = 0.007), and T classification (OR = 13.304 for T2 vs. T1, P = 0.014; OR = 18.434 for T3 vs. T1, P = 0.005; OR = 30.649 for T4 vs. T1, P = 0.001). The Kaplan–Meier curves suggested that patients with high LUM expression had a poor prognosis. Multivariate analysis showed that a high expression of LUM was an important independent predictor of poor overall survival (HR, 1.189; 95% CI, 1.011–1.400; P = 0.037). GSEA indicated that 14 signaling pathways were evidently enriched in samples with the high-LUM expression phenotype. Conclusions: LUM might act as an oncogene in the progression of GC and could be regarded as a potential prognostic indicator and therapeutic target for GC. Frontiers Media S.A. 2020-05-15 /pmc/articles/PMC7242722/ /pubmed/32500021 http://dx.doi.org/10.3389/fonc.2020.00605 Text en Copyright © 2020 Chen, Li, Hu, Jiang, Shen, Xu, Wu, Wei and Shen. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Chen, Xiaowei Li, Xin Hu, Xueju Jiang, Fei Shen, Yan Xu, Rui Wu, Leilei Wei, Pingmin Shen, Xiaobing LUM Expression and Its Prognostic Significance in Gastric Cancer |
title | LUM Expression and Its Prognostic Significance in Gastric Cancer |
title_full | LUM Expression and Its Prognostic Significance in Gastric Cancer |
title_fullStr | LUM Expression and Its Prognostic Significance in Gastric Cancer |
title_full_unstemmed | LUM Expression and Its Prognostic Significance in Gastric Cancer |
title_short | LUM Expression and Its Prognostic Significance in Gastric Cancer |
title_sort | lum expression and its prognostic significance in gastric cancer |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242722/ https://www.ncbi.nlm.nih.gov/pubmed/32500021 http://dx.doi.org/10.3389/fonc.2020.00605 |
work_keys_str_mv | AT chenxiaowei lumexpressionanditsprognosticsignificanceingastriccancer AT lixin lumexpressionanditsprognosticsignificanceingastriccancer AT huxueju lumexpressionanditsprognosticsignificanceingastriccancer AT jiangfei lumexpressionanditsprognosticsignificanceingastriccancer AT shenyan lumexpressionanditsprognosticsignificanceingastriccancer AT xurui lumexpressionanditsprognosticsignificanceingastriccancer AT wuleilei lumexpressionanditsprognosticsignificanceingastriccancer AT weipingmin lumexpressionanditsprognosticsignificanceingastriccancer AT shenxiaobing lumexpressionanditsprognosticsignificanceingastriccancer |